• Overcoming Limitations in Eye Care Therapies

    Our technology, opens completely new and intriguing opportunities to cure, relief and prevent diseases in various areas of indications for patients.

Novaliq’s innovative EyeSol® technology is based on novel and exclusive water-free excipients and opens open completely new and intriguing opportunities to cure, relief and prevent diseases in various indications:

  • the technology is clinically proven to be safe and effective.
  • EyeSol® substances are highly biocompatible and do not accumulate in human tissues

  • the technology platform is proprietary to Novaliq and IP protected.
  • rich Pipeline with first- and best-in-class candidates for a variety of ocular and non-ocular therapies.

EyeSol® benefits for topical ocular applications:

For our products we only use highly pure substances and raw materials from qualified manufacturers. We have extensively tested and proven their safety, efficacy and tolerability in close cooperation with the regulatory authorities in Europe and USA, both preclinically and clinically.